missing translation for 'onlineSavingsMsg'
Få mere at vide
Få mere at vide
Description
RECTAS (rectifier of aberrant splicing) is a pre-mRNA splicing modulator of the IKBKAP (inhibitor of κ light polypeptide gene enhancer in B-cells, kinase complex associated protein) gene. It corrects aberrant IKBKAP splicing in vitro in cellular models of familial dysautonomia and in vivo in transgenic mice. In combination with Phenylbutyric acid (Cat. No. 2682), RECTAS rescues PARK7 aberrant splicing and neuronal cell loss in a midbrain organoid model of familial Parkinson's disease. Orally bioavailable and brain penetrant.
Greener Choice-anprisninger
- undefined
- Ozone-Safe or Safe for the Ozone Layer

Specifications
Specifications
Kemisk navn eller materiale | 2-Chloro-N-(2-furanylmethyl)-7 H-purin-6-amine |
CAS | 101862-47-9 |
Mængde | 10 mg |
Mål | DNA, RNA and Protein Synthesis Compounds |
Molekylær formel | C10H8ClN5O |
Renhed | 0.98 |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Tocris Bioscience™ RECTAS >
Spot an opportunity for improvement?Share a Content Correction